What does the evidence say about Calcium Kidney Stones Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Calcium Kidney Stones Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Introduction Primary hyperparathyroidism (PHPT) increases the risk of renal stones and progressive renal dysfunction. [Jay M (2026); evidence level 1] - Two reviewers will independently screen records, extract data and assess risk of bias (Cochrane Risk-of-Bias 2 and Risk Of Bias In Non-randomised Studies of Interventions). [Jay M (2026); evidence level 1] - Publication bias will be assessed using appropriate quantitative or qualitative methods based on the available evidence. [Jay M (2026); evidence level 1] - Parathyroidectomy is recommended for patients with renal involvement, yet whether surgery improves renal outcomes compared with non-surgical management remains unclear. [Jay M (2026); evidence level 1] - Traditional risk factors for calcium oxalate urolithiasis include high oxalate intake (e.g. [Pang Shuo (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.